Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-ND5 pseudogene 4 (MTND5P4) is a nuclear pseudogene related to the mitochondrial gene encoding NADH:ubiquinone oxidoreductase core subunit 5 (MT-ND5), a critical protein of mitochondrial complex I[4][2]. Unlike the functional mitochondrial gene, this pseudogene contains mutations—including premature stop codons—that prevent it from being translated into a functional protein[1]. As such, it does not play a direct role in cellular metabolism or serve as a therapeutic target like true enzymes, receptors, or transporters. Its designation in the genome reflects sequence homology but not function; pseudogenes like MTND5P4 do not produce active proteins and are generally not involved in drug action or disease mechanisms, though some nuclear pseudogenes may have regulatory functions in rare cases[1][2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5 pseudogene 4 (MTND5P4).